A

Arcturus Therapeutics Holdings
D

ARCT

17.040
USD
0.84
(5.19%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-6
Market Cap
460,799,872
OverviewSignalsIdeasNews
Related Instruments
    A
    ACCO
    -0.20000
    (-3.32%)
    5.82000 USD
    E
    EVO
    0.33500
    (6.56%)
    5.44500 USD
    More
News

Title: Arcturus Therapeutics Holdings

Sector: Healthcare
Industry: Biotechnology
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.